Latest Ratings for SFM Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Feb 2022 Credit Suisse Maintains Neutral Feb 2022 Deutsche Bank Maintains Buy View More Analyst Ratings for SFM View the Latest Analyst Ratings read more
Latest Ratings for EVER Date Firm Action From To Feb 2022 Needham Maintains Buy Feb 2022 Raymond James Maintains Outperform Dec 2021 JP Morgan Downgrades Neutral Underweight View More Analyst Ratings for EVER View the Latest Analyst Ratings read more
Latest Ratings for JWN Date Firm Action From To Mar 2022 JP Morgan Maintains Underweight Mar 2022 Credit Suisse Maintains Neutral Mar 2022 Telsey Advisory Group Maintains Market Perform View More Analyst Ratings for JWN View the Latest Analyst Ratings read more
Strategy (NASDAQ:MSTR) declined 5.1% in the pre-market trading session on Tuesday after Bitcoin plummeted over 7% in the last 24 hours, according to data from Benzinga Pro. read more
Virax Biolabs supports HHS’s focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research. read more
Putin offers US access to Russian metals as alternative to US push for Ukraine’s resources. He also proposes joint projects and investment opportunities. read more
US markets mixed, tech stocks down on AI demand concerns and weak economic indicators. Japan’s Nikkei falls, oil prices rise on US sanctions. read more
The South Dakota legislature delayed a vote on a bill on Monday that could have allowed the state to adopt Bitcoin (CRYPTO: BTC) as a strategic reserve asset. read more
Warren Buffett’s 2005 deal to acquire Forest River became one of Berkshire Hathaway’s most successful acquisitions. read more
Alibaba Group declined on Monday and Tuesday triggered by President Donald Trump’s remarks to limit Chinese spending and investment. read more